Acid (LSD) is neither an upper nor a downer. It belongs to a third category of drugs called hallucinogens, which work through entirely different brain pathways than stimulants or depressants. That said, LSD does produce some stimulant-like effects, which is why the question comes up so often.
Why LSD Doesn’t Fit Either Category
Uppers like cocaine and amphetamines flood the brain with dopamine, speeding up the central nervous system. Downers like alcohol and opioids slow it down. LSD does something fundamentally different: it acts primarily on serotonin receptors, specifically a subtype involved in perception and cognition. This interaction is what produces the hallmark effects of a psychedelic experience, including visual distortions, altered sense of time, synesthesia (where you might “see” sounds or “hear” colors), and deep shifts in mood and thought patterns.
LSD also interacts with dopamine and adrenaline receptors to a lesser degree, which explains why the experience can feel energizing. But its core mechanism sets it apart from both stimulants and depressants.
Why It Feels Like an Upper
LSD raises heart rate, blood pressure, body temperature, and pupil size. It also increases levels of cortisol and adrenaline in the blood. These are all hallmarks of stimulant drugs, and in a clinical setting, researchers have described LSD as producing “significant sympathomimetic stimulation,” meaning it activates the body’s fight-or-flight responses.
At low doses, the subjective effects are even more strikingly stimulant-like. A study published in Neuropsychopharmacology found that small amounts of LSD increased ratings of energy, positive mood, elation, and intellectual efficiency, effects comparable to low doses of amphetamine. This is partly because LSD influences dopamine activity in the brain’s reward circuits, the same system that stimulants target directly.
So while LSD is not pharmacologically a stimulant, your body can respond to it as though it were one. You’re unlikely to feel sedated or sluggish on acid. Most people feel wide awake, mentally active, and physically alert for the entire duration of the trip.
What the Experience Looks Like Over Time
LSD’s timeline is much longer than most uppers or downers, and this is one of its most distinctive features. Effects typically begin within 30 to 60 minutes of taking a dose. The peak hits around 2 to 3 hours in and can last several hours. Total duration ranges from 8 to 12 hours, with residual effects sometimes lingering for a day or two afterward. In clinical studies using a standard dose, researchers measured the full experience lasting anywhere from 5 to 14 hours, with higher doses stretching as long as 19 hours.
The comedown from LSD is also different from a stimulant crash. After amphetamines or cocaine, the body tries to restore its depleted dopamine levels, often leaving people feeling exhausted, irritable, and depressed. After a downer wears off, the rebound tends toward anxiety and agitation. LSD’s aftermath is less predictable. Some people feel mentally drained and have difficulty sleeping, while others describe a lingering sense of openness or emotional clarity. The physical crash that defines stimulant use isn’t typically part of the LSD experience.
LSD’s Unusual Safety Profile
One area where LSD differs sharply from both uppers and downers is physical toxicity. No lethal dose has been established for humans. The gap between an active dose (100 to 200 micrograms) and anything approaching danger is enormous. In one of the most extreme documented cases, a 46-year-old woman accidentally snorted 55,000 micrograms of LSD (275 to 550 times a typical dose) after mistaking it for cocaine. She survived without lasting health consequences.
Stimulants and depressants, by comparison, have much narrower margins of safety. MDMA’s estimated lethal dose for a 70-kilogram person is roughly 2 grams, only about 15 to 16 times a single recreational dose. Opioids and alcohol are notoriously easy to fatally overdose on. LSD’s primary risks are psychological, not physical: bad trips, panic reactions, and dangerous behavior driven by distorted perception. The drug’s effects are unpredictable, and a positive experience one time does not guarantee the same result the next.
Where Hallucinogens Sit in the Bigger Picture
The upper/downer framework is useful shorthand, but it only covers two of the three major drug categories. Hallucinogens, which include LSD, psilocybin (magic mushrooms), and mescaline, form their own class defined by profound changes in consciousness, emotion, and perception rather than simple acceleration or suppression of brain activity. Some hallucinogens lean more stimulating (LSD, mescaline), while others feel more sedating (certain strains of psilocybin mushrooms), but none of them fit cleanly into either box.
LSD is currently being studied as a potential treatment for major depression, with a phase 3 clinical trial underway. Early results show promise, driven partly by LSD’s ability to engage both serotonin and dopamine pathways in ways that conventional antidepressants do not. This dual action is another reminder that the drug operates outside the simple stimulant/depressant binary, doing things in the brain that neither category can fully explain.